Donaldson Company, Inc
Bloomington, Minnesota, United States
Purpose
To reduce the cost of monoclonal antibodies to enable affordable prevention and treatment of infectious diseases for people in low-and middle-income countries.
Division
Global Health
Date
September 2025
Region Served
GLOBAL
Committed amount
$2,097,718
Grant topic
Vaccine Development
Duration (months)
27
Grantee location
Bloomington, Minnesota, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.